Non-profit group TransCelerate BioPharma Inc. has brought together several working groups to identify more efficient and effective approaches to the process of new drug development. In this podcast, Dr. Stephen P Spielberg discusses efforts to improve monitoring of clinical trials with key contributors to the TransCelerate efforts. Participants are Nicole Sheetz, Advisor, Clinical Innovation and Implementation, Eli Lilly and Company, Brett Wilson, Associate Director, Central Clinical Services, R&D Operations, Bristol-Myers Squibb; and Mark Travers, Vice President, Head of Clinical Study Units, Clinical Sciences & Operations, Sanofi.  

Read full article here.